MDT

88.32

+0.83%↑

A

120.68

+3.05%↑

VEEV

157.23

-0.23%↓

HQY

80.02

+0.41%↑

TLRY

6.85

+1.63%↑

MDT

88.32

+0.83%↑

A

120.68

+3.05%↑

VEEV

157.23

-0.23%↓

HQY

80.02

+0.41%↑

TLRY

6.85

+1.63%↑

MDT

88.32

+0.83%↑

A

120.68

+3.05%↑

VEEV

157.23

-0.23%↓

HQY

80.02

+0.41%↑

TLRY

6.85

+1.63%↑

MDT

88.32

+0.83%↑

A

120.68

+3.05%↑

VEEV

157.23

-0.23%↓

HQY

80.02

+0.41%↑

TLRY

6.85

+1.63%↑

MDT

88.32

+0.83%↑

A

120.68

+3.05%↑

VEEV

157.23

-0.23%↓

HQY

80.02

+0.41%↑

TLRY

6.85

+1.63%↑

Search

Omnicell Inc

Abierto

SectorSanidad

36.18 3.91

Resumen

Variación precio

24h

Actual

Mínimo

34.53

Máximo

36.2

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

852.75

66.418

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+67.88% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-687M

1.5B

Apertura anterior

32.27

Cierre anterior

36.18

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

51 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 abr 2026, 23:25 UTC

Noticias de Eventos Importantes

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 abr 2026, 22:45 UTC

Noticias de Eventos Importantes

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 abr 2026, 18:03 UTC

Ganancias

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 abr 2026, 23:58 UTC

Ganancias

Review & Preview: Earnings Time -- Barrons.com

13 abr 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 abr 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 abr 2026, 23:20 UTC

Charlas de Mercado

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 abr 2026, 23:01 UTC

Ganancias

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 abr 2026, 23:01 UTC

Ganancias

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 abr 2026, 23:01 UTC

Ganancias

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 abr 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 abr 2026, 21:53 UTC

Ganancias

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 abr 2026, 21:26 UTC

Noticias de Eventos Importantes

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 abr 2026, 21:23 UTC

Ganancias

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 abr 2026, 21:16 UTC

Ganancias

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 abr 2026, 20:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

13 abr 2026, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 abr 2026, 20:34 UTC

Ganancias

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 abr 2026, 19:59 UTC

Charlas de Mercado

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 abr 2026, 19:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 abr 2026, 19:27 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Correction to Precious Metals Market Talk on April 9

13 abr 2026, 19:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 abr 2026, 18:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 abr 2026, 18:59 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 abr 2026, 18:43 UTC

Charlas de Mercado

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

67.88% repunte

Estimación a 12 Meses

Media 57.75 USD  67.88%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

51 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat